Affiliation:
1. Hôpital de Bicêtre, Paris, France
Abstract
Naftidrofuryl (Praxilene) has been shown experimentally to improve the metabolism of brain cells where this has been impaired by advancing ischaemia due to arteriosclerosis. It has been evaluated in warded chronic patients showing signs of impaired intellectual ability. The trial was performed double-blind involving an identical placebo and the results assessed using psychometric tests and analyzed statistically. The results confirm the effectiveness of Naftidrofuryl (Praxilene) in improving intellectual performance and this was particularly apparent in the less severely affected.
Subject
Biochemistry, medical,Cell Biology,Biochemistry,General Medicine
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Naftidrofuryl for dementia;Cochrane Database of Systematic Reviews;2011-12-07
2. Naftidrofuryl;Neuro-Psychopharmaka Ein Therapie-Handbuch;1999
3. Naftidrofuryl;Neuro-Psychopharmaka;1992
4. Naftidrofuryl in the Treatment of Mild Senile Dementia;Pharmacopsychiatry;1990-11
5. A Randomized Double-blind Controlled Trial of Naftidrofuryl in Acute Stroke;Age and Ageing;1990